2,0
6. März 2015
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
the people at the astrazeneca/ amylin site was great and very easy to work with
Kontras
Being in a transitional company, from Amylin to BMS to Astrazeneca, room for personal development was not there as the group was in an ongoing company transition.